Growth Metrics

ImmunityBio (IBRX) Share-based Compensation (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.60%
Dec 31, 2025 -1.49%
Sep 30, 2025 -7.98%
Jun 30, 2025 1.16%
Mar 31, 2025 5.52%
Dec 31, 2024 20.68%
Sep 30, 2024 -22.31%
Jun 30, 2024 16.61%
Mar 31, 2024 -35.29%
Dec 31, 2023 -11.59%
Sep 30, 2023 30.62%
Jun 30, 2023 1.69%
Mar 31, 2023 16.34%
Dec 31, 2022 -12.04%
Sep 30, 2022 4.47%
Jun 30, 2022 1.51%
Mar 31, 2022 -1.53%
Dec 31, 2021 -26.45%
Sep 30, 2021 -22.52%
Jun 30, 2021 16.77%
Mar 31, 2021 2,179.88%
Dec 31, 2020 -5.63%
Sep 30, 2020 120.81%
Jun 30, 2020 -32.92%
Mar 31, 2020 -62.23%
Dec 31, 2019 358.84%
Sep 30, 2019 -46.93%
Jun 30, 2019 -61.36%
Mar 31, 2019 -3.98%
Dec 31, 2018 -64.54%
Sep 30, 2018 -55.59%
Jun 30, 2018 -1.53%
Mar 31, 2018 2.13%
Dec 31, 2017 1.95%
Sep 30, 2017 -7.11%
Jun 30, 2017 -6.36%
Mar 31, 2017 -11.08%
Dec 31, 2016 -39.65%
Sep 30, 2016 -20.06%
Jun 30, 2016 13.58%
Mar 31, 2016 -3.94%
Dec 31, 2015 -45.10%
Sep 30, 2015 -69.13%
Jun 30, 2015 415.08%
Mar 31, 2015 4,035.41%
Dec 31, 2014 1,944.83%
Sep 30, 2014 -9.38%